UNICYCIVE THERAPEUTICS, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $77.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2023-11-14
- UNICYCIVE THERAPEUTICS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $77.00M.
- UNICYCIVE THERAPEUTICS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $44.00K.
- UNICYCIVE THERAPEUTICS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $152.00K, a 1.30% decline from fiscal 2021.
- UNICYCIVE THERAPEUTICS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $154.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|
| 2023-09-30 | $77.00M 10-Q · filed 2023-11-14 | $196.00M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $44.00K 10-Q · filed 2023-05-16 | ||
| 2022-12-31 | $152.00K 10-K · filed 2023-03-31 | ||
| 2021-12-31 | $154.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |